Introduction {#s1}
============

> *"Social relationships, or the relative lack thereof, constitute a major risk factor for health---rivaling the effect of well established health risk factors such as cigarette smoking, blood pressure, blood lipids, obesity and physical activity"*
>
> ---House, Landis, and Umberson; *Science* 1988 [@pmed.1000316-House1]

Two decades ago a causal association between social relationships and mortality was proposed after a review of five large prospective studies concluded that social relationships predict mortality [@pmed.1000316-House1]. Following the publication of this provocative review, the number of prospective studies of mortality that included measures of social relationships increased exponentially. Although the inverse association between social relationships and nonsuicide mortality has received increased attention in research, neither major health organizations nor the general public recognize it as a risk factor for mortality. This may be due in part to the fact that the literature has become unwieldy, with wide variation in how social relationships are measured across a large number of studies and disappointing clinical trials [@pmed.1000316-Berkman1]. "Social relationships" has perhaps become viewed as a fuzzy variable, lacking the level of precision and control that is preferred in biomedical research. Thus, the large corpus of relevant empirical research is in need of synthesis and refinement.

Current evidence also indicates that the quantity and/or quality of social relationships in industrialized societies are decreasing. For instance, trends reveal reduced intergenerational living, greater social mobility, delayed marriage, dual-career families, increased single-residence households, and increased age-related disabilities [@pmed.1000316-McPherson1],[@pmed.1000316-Putnam1]. More specifically, over the last two decades there has been a three-fold increase in the number of Americans who report having no confidant---now the modal response [@pmed.1000316-McPherson1]. Such findings suggest that despite increases in technology and globalization that would presumably foster social connections, people are becoming increasingly more socially isolated. Given these trends, understanding the nature and extent of the association between social relationships and mortality is of increased temporal importance.

There are two general theoretical models that propose processes through which social relationships may influence health: the stress buffering and main effects models [@pmed.1000316-Cohen1]. The buffering hypothesis suggests that social relationships may provide resources (informational, emotional, or tangible) that promote adaptive behavioral or neuroendocrine responses to acute or chronic stressors (e.g., illness, life events, life transitions). The aid from social relationships thereby moderates or *buffers* the deleterious influence of stressors on health. From this perspective, the term *social support* is used to refer to the real or perceived availability of social resources [@pmed.1000316-Cohen2]. The main effects model proposes that social relationships may be associated with protective health effects through more direct means, such as cognitive, emotional, behavioral, and biological influences that are not explicitly intended as help or support. For instance, social relationships may directly encourage or indirectly model healthy behaviors; thus, being part of a social network is typically associated with conformity to social norms relevant to health and self-care. In addition, being part of a social network gives individuals meaningful roles that provide self-esteem and purpose to life [@pmed.1000316-Cohen3],[@pmed.1000316-Thoits1].

Social relationships have been defined and measured in diverse ways across studies. Despite striking differences, three major components of social relationships are consistently evaluated [@pmed.1000316-Cohen1]: (a) the degree of integration in social networks [@pmed.1000316-Brissette1], (b) the social interactions that are intended to be supportive (i.e., received social support), and (c) the beliefs and perceptions of support availability held by the individual (i.e., perceived social support). The first subconstruct represents the structural aspects of social relationships and the latter two represent the functional aspects. Notably, these different subconstructs are only moderately intercorrelated, typically ranging between *r* = 0.20 and 0.30 [@pmed.1000316-Brissette1],[@pmed.1000316-Reinhardt1]. While all three components have been shown to be associated with morbidity and mortality, it is thought that each may influence health in different ways [@pmed.1000316-Lakey1],[@pmed.1000316-Cohen4]. Because it is presently unclear whether any single aspect of social relationships is more predictive than others, synthesis of data across studies using several types of measures of social relationships would allow for essential comparisons that have not been conducted on such a large scale.

Empirical data suggest the medical relevance of social relationships in improving patient care [@pmed.1000316-DiMatteo1], increasing compliance with medical regimens [@pmed.1000316-DiMatteo1], and promoting decreased length of hospitalization [@pmed.1000316-Murphy1],[@pmed.1000316-Lett1]. Likewise, social relationships have been linked to the development [@pmed.1000316-Knox1],[@pmed.1000316-Kop1] and progression [@pmed.1000316-Brummett1]--[@pmed.1000316-Angerer1] of cardiovascular disease [@pmed.1000316-Knox2]---a leading cause of death globally. Therefore, synthesis of the current empirical evidence linking social relationships and mortality, along with clarifications of potential moderators, may be particularly relevant to public health and clinical practice for informing interventions and policies aimed at reducing risk for mortality.

To address these issues, we conducted a meta-analysis of the literature investigating the association between social relationships and mortality. Specifically, we addressed the following questions: What is the overall magnitude of the association between social relationships and mortality across research studies? Do structural versus functional aspects of social relationships differentially impact the risk for mortality? Is the association moderated by participant characteristics (age, gender, health status, cause of mortality) or by study characteristics (length of clinical follow-up, inclusion of statistical controls)? Is the influence of social relationships on mortality a gradient or threshold effect?

Methods {#s2}
=======

Identification of Studies {#s2a}
-------------------------

To identify published and unpublished studies of the association between social relationships and mortality, we used three techniques. First, we conducted searches of studies from January 1900 to January 2007 using several electronic databases: Dissertation Abstracts, HealthSTAR, Medline, Mental Health Abstracts, PsycINFO, Social Sciences Abstracts, Sociological Abstracts via SocioFile, Academic Search Premier, ERIC, and Family & Society Studies Worldwide. To capture the broadest possible sample of relevant articles, we used multiple search terms, including *mortality*, *death*, *decease(d)*, *died*, *dead*, and *remain(ed) alive*, which were crossed with search words related to social relationships, including the terms *social* and *interpersonal* linked to the following words: *support*, *network*, *integration*, *participation*, *cohesion*, *relationship*, *capital*, *and isolation* To reduce inadvertent omissions, we searched databases yielding the most citations (Medline, PsycINFO) two additional times. Next, we manually examined the reference sections of past reviews and of studies meeting the inclusion criteria to locate articles not identified in the database searches. Finally, we sent solicitation letters to authors who had published three or more articles on the topic.

Inclusion Criteria {#s2b}
------------------

We included in the meta-analysis studies that provided quantitative data regarding individuals\' mortality as a function of social relationships, including both structural and functional aspects [@pmed.1000316-Cohen5]. Because we were interested in the impact of social relationships on disease, we excluded studies in which mortality was a result of suicide or injury. We also excluded studies in which the only measurement of social support was an intervention provided within the context of the study (e.g., support group), the source of social support was nonhuman (e.g., a pet or higher power), or the social support was provided to others (i.e., giving support to others or measures of others\' benefit from the support provided) rather than to the individual tracked for mortality status. We coded studies that included participant marital status as one of several indicators of social support, but we excluded studies in which marital status was the only indicator of social support. We also excluded studies in which the outcome was not explicitly and solely mortality (e.g., combined outcomes of morbidity/mortality). Reports with exclusively aggregated data (e.g., census-level statistics) were also excluded. Manuscripts coded were all written in English, which accounted for 98% of the total retrieved. See [Figure 1](#pmed-1000316-g001){ref-type="fig"} for additional details.

![Flow diagram.](pmed.1000316.g001){#pmed-1000316-g001}

Data Abstraction {#s2c}
----------------

To increase the accuracy of coding and data entry, each article was initially coded by two raters. Subsequently, the same article was independently coded by two additional raters. Coders extracted several objectively verifiable characteristics of the studies: (a) the number of participants and their composition by age, gender, marital status, distress level, health status, and pre-existing health conditions (if any), as well as the percentage of smokers and percentage of physically active individuals, and, of course, the cause of mortality; (b) the length of follow up; (c) the research design; and (d) the aspect of social relationships evaluated.

Data within studies were often reported in terms of odds ratios (ORs), the likelihood of mortality across distinct levels of social relationships. Because OR values cannot be meaningfully aggregated, all effect sizes reported within studies were transformed to the natural log OR (lnOR) for analyses and then transformed back to OR for interpretation. When effect size data were reported in any metric other than OR or lnOR, we transformed those values using statistical software programs and macros (e.g., Comprehensive Meta-Analysis [@pmed.1000316-Borenstein1]). In some cases when direct statistical transformation proved impossible, we calculated the corresponding effect sizes from frequency data in matrices of mortality status by social relationship status. When frequency data were not reported, we recovered the cell probabilities from the reported ratio and marginal probabilities. When survival analyses (i.e., hazard ratios) were reported, we calculated the effect size from the associated level of statistical significance, often derived from 95% confidence intervals (CIs). Across all studies we assigned OR values less than 1.00 to data indicative of increased mortality and OR values greater than 1.00 to data indicative of decreased mortality for individuals with relatively higher levels of social relationships.

When multiple effect sizes were reported within a study at the same point in time (e.g., across different measures of social relationships), we averaged the several values (weighted by standard error) to avoid violating the assumption of independent samples. In such cases, the aggregate standard error value for the lnOR were estimated on the basis of the total frequency data without adjustment for possible correlation among the averaged values. Although this method was imprecise, the manuscripts included in the meta-analysis did not report the information necessary to make the statistical adjustments, and we decided not to impute values given the wide range possible. In analyzing the data we used the shifting units of analysis approach [@pmed.1000316-Cooper1] which minimizes the threat of nonindependence in the data while at the same time allowing more detailed follow-up analyses to be conducted (i.e., examination of effect size heterogeneity).

When multiple reports contained data from the same participants (publications of the same database), we selected the report containing the whole sample and eliminated reports of subsamples. When multiple reports contained the same whole sample, we selected the one with the longest follow-up duration. When multiple reports with the same whole sample were of the same duration, we selected the one reporting the greatest number of measures of social relationships.

In cases where multiple effect sizes were reported across different levels of social relationships (i.e., high versus medium, medium versus low), we extracted the value with the greatest contrast (i.e., high versus low). When a study contained multiple effect sizes across time, we extracted the data from the longest follow-up period. If a study used statistical controls in calculating an effect size, we extracted the data from the model utilizing the fewest statistical controls so as to remain as consistent as possible across studies (and we recorded the type and number of covariates used within each study to run post hoc comparative analyses). We coded the research design used rather than estimate risk of individual study bias. The coding protocol is available from the authors.

The majority of information obtained from the studies was extracted verbatim from the reports. As a result, the inter-rater agreement was quite high for categorical variables (mean Cohen\'s *kappa* = 0.73, *SD* = 0.13) and for continuous variables (mean intraclass correlation [@pmed.1000316-Shrout1] = 0.80, *SD* = .14). Discrepancies across coding pairs were resolved through further scrutiny of the manuscript until consensus was obtained.

Aggregate effect sizes were calculated using random effects models following confirmation of heterogeneity. A random effects approach produces results that generalize beyond the sample of studies actually reviewed [@pmed.1000316-Hedges1]. The assumptions made in this meta-analysis clearly warrant this method: The belief that certain variables serve as moderators of the observed association between social relationships and mortality implies that the studies reviewed will estimate different population effect sizes. Random effects models take such between-studies variation into account, whereas fixed effects models do not [@pmed.1000316-Mosteller1]. In each analysis conducted, we examined the remaining variance to confirm that random effects models were appropriate.

Results {#s3}
=======

Statistically nonredundant effect sizes were extracted from 148 studies ([@pmed.1000316-Ahern1]--[@pmed.1000316-Zuckerman1]; see [Table 1](#pmed-1000316-t001){ref-type="table"}). Data were reported from 308,849 participants, with 51% from North America, 37% from Europe, 11% from Asia, and 1% from Australia. Across all studies, the average age of participants at initial evaluation was 63.9 years, and participants were evenly represented across sex (49% female, 51% male). Of the studies examined, 60% involved community samples, but 24% examined individuals receiving outpatient medical treatment, and 16% utilized patients in inpatient medical settings. Of studies involving patients with a pre-existing diagnosis, 44% were specific to cardiovascular disease (CVD), 36% to cancer, 9% to renal disease, and the remaining 11% had a variety of conditions including neurological disease. Research reports most often (81%) considered all-cause mortality, but some restricted evaluations to mortality associated with cancer (9%), CVD (8%), or other causes (2%). Participants were followed for an average of 7.5 years (*SD* = 7.1, range = 3 months to 58 years), with an average of 29% of the participants dying within each study\'s follow-up period.
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###### Overview of the 148 studies included in the meta-analysis.

![](pmed.1000316.t001){#pmed-1000316-t001-1}

  Source                                                                Total Number of Participants   Average Age at Intake   Location of Study   Study Length   Cause of Mortality   Social Relationship Measure   Original Statistic Metric    lnOR    Standard Error
  -------------------------------------------------------------------- ------------------------------ ----------------------- ------------------- -------------- -------------------- ----------------------------- --------------------------- -------- ----------------
  Ahern et al., 1990 [@pmed.1000316-Ahern1]                                         353                         50                    USA              1 y            All-cause                Functional                     M & SD              0.27         0.36
  Alter et al., 2006 [@pmed.1000316-Alter1]                                        3,138                        64                  Canada           5 y 4 m             CVD                    Combined                        Chi               0.06         0.15
  Anstey et al., 2002 [@pmed.1000316-Anstey1]                                      2,065                        78                 Australia           9 y            All-cause                Structural                      Freq               0.44         0.09
  Astrand et al., 1989 [@pmed.1000316-Astrand1]                                     391                         50                  Sweden             22 y           All-cause                 Combined                        OR                0.00         0.18
  Avlund et al., 1998 [@pmed.1000316-Avlund1]                                       727                         70                  Denmark            11 y           All-cause                 Combined                        OR                0.40         0.16
  Avlund et al., 2004 [@pmed.1000316-Avlund2]                                       565                         75             Denmark, Finland        5 y            All-cause                Structural                       OR                0.54         0.22
  Barefoot et al., 2005 [@pmed.1000316-Barefoot1]                                  3,109                        58                  Denmark          7 y 2 m          All-cause                Structural                        p                0.15         0.12
  Berkman and Syme, 1979 [@pmed.1000316-Berkman2]                                  4,765                        47                    USA              9 y            All-cause                Structural                      Freq               0.60         0.30
  Berkman et al., 2004 [@pmed.1000316-Berkman3]                                    3,495                        45                  France             10 y           All-cause                Structural                       RR                1.61         0.14
  Birket-Smith et al., 1989 [@pmed.1000316-BirketSmith1]                            128                         73                  Denmark            1 y            All-cause                Structural                        R                0.37         0.33
  Blazer, 1982 [@pmed.1000316-Blazer1]                                              331                         72                    USA            2 y 6 m          All-cause                 Combined                        RR                1.05         0.30
  Blazer et al., 2001 [@pmed.1000316-Blazer2]                                      3,664                        73                    USA              3 y            All-cause                 Combined                        OR                0.15         0.10
  Bowling, 1989 [@pmed.1000316-Bowling1]                                            503                         73                    UK               6 y            All-cause                Structural                       Chi               0.51         0.16
  Brown et al., 2003 [@pmed.1000316-Brown1]                                         846                         NR                    USA              5 y            All-cause                 Combined                        OR                0.01         0.22
  Brummet et al., 2005 [@pmed.1000316-Brummett2]                                   2,711                        62                    USA            11 y 1m          All-cause                Functional                        p                0.25         0.17
  Burg et al., 2005 [@pmed.1000316-Burg1]                                          1,899                        75                    USA            2 y 5 m          All-cause                 Combined                       Freq               1.39         0.28
  Burns et al., 2005 [@pmed.1000316-Burns1]                                         147                         63                 Australia         7 y 4 m            Cancer                  Combined                      Combin              0.45         0.31
  Butow et al., 1999 [@pmed.1000316-Butow1]                                         125                         55                 Australia           2 y              Cancer                  Combined                         p                0.35         0.33
  Bygren et al., 1996 [@pmed.1000316-Bygren1]                                      12,675                       43                  Sweden             9 y            All-cause                Structural                      Freq               0.41         0.07
  Case et al., 1992 [@pmed.1000316-Case1]                                          1,195                        59                Canada, USA        4 y 2 m             CVD                   Structural                       RR                0.68         0.25
  Cassileth et al., 1988 [@pmed.1000316-Cassileth1]                                 203                         60                    USA              8 y              Cancer                 Structural                     Combin             −0.03         0.26
  Ceria et al., 2001 [@pmed.1000316-Ceria1]                                        1,786                        78                    USA              6 y            All-cause                Structural                       RR                1.01         0.12
  Chacko et al., 1996 [@pmed.1000316-Chacko1]                                        94                         53                    USA            4 y 8 m             CVD                   Functional                       Chi               0.92         0.39
  Christensen et al., 1999 [@pmed.1000316-Christensen1]                             133                         29                    USA            58 y 2m          All-cause                 Combined                        Chi               0.98         0.32
  Christensen et al., 1994 [@pmed.1000316-Christensen2]                              78                         54                    USA              5 y            All-cause                Functional                       Chi               0.98         0.44
  Cohen et al., 1987 [@pmed.1000316-Cohen6]                                         155                         73                    USA              3 y            All-cause                Structural                        T                0.65         0.30
  Colon et al., 1991 [@pmed.1000316-Colon1]                                         100                         30                    USA              2 y              Cancer                 Functional                       Chi               0.86         0.38
  Cornman et al., 2003 [@pmed.1000316-Cornman1]                                    4,049                        NR                  Taiwan             3 y            All-cause                Structural                       OR                0.17         0.06
  Coyne et al., 2001 [@pmed.1000316-Coyne1]                                         189                         53                    USA              4 y               CVD                   Functional                       RR                0.99         0.26
  Cree et al., 2000 [@pmed.1000316-Cree1]                                           558                         82                  Canada             4 m            All-cause                Functional                       OR                0.30         0.34
  Cuijpers, 2001 [@pmed.1000316-Cuijpers1]                                          424                         85                Netherlands          1 y            All-cause                Functional                       OR               −0.10         0.31
  Dalgard & Haheim, 1998 [@pmed.1000316-Dalgard1]                                  1,002                        46                  Norway             17 y           All-cause                Structural                        p                0.23         0.15
  Devins et al., 1990 [@pmed.1000316-Devins1]                                        97                         40                  Canada             4 y              Other                  Structural                        R               −0.025        0.38
  Dickens et al., 2004 [@pmed.1000316-Dickens1]                                     556                         60                    UK               1 y               CVD                   Functional                        p                0.65         0.45
  Ell et al., 1992 [@pmed.1000316-Ell1]                                             294                         61                    USA            6 y 11m          All-cause                 Combined                         p               −0.15         0.21
  Eng et al., 2002 [@pmed.1000316-Eng1]                                            16,242                       55                    USA              10 y           All-cause                Structural                       RR                0.42         0.06
  Engedal,1996 [@pmed.1000316-Engedal1]                                             334                         82                  Norway             3 y            All-cause                Structural                     M & SD              0.62         0.20
  Farmer et al., 1996 [@pmed.1000316-Farmer1]                                       320                         60                    USA             4 y 7m          All-cause                 Combined                        RR                0.81         0.22
  Forster & Stoller, 1992 [@pmed.1000316-Forster1]                                  363                         74                    USA              7 y            All-cause                 Combined                       LnOR              −0.20         0.22
  Frasure-Smith et al., 2000 [@pmed.1000316-FrasureSmith1]                          887                         59                  Canada             1 y               CVD                   Functional                        p                0.09         0.12
  Frick et al., 2005 [@pmed.1000316-Frick1]                                          99                         55                  Germany          3 y 11m            Cancer                  Combined                         p                0.23         0.35
  Fry and Debats, 2006 [@pmed.1000316-Fry1]                                         380                         75                  Canada           5 y 11m          All-cause                 Combined                        RR                0.78         0.24
  Fuhrer et al., 1999 [@pmed.1000316-Fuhrer1]                                      3,777                        76                  France             5 y            All-cause                 Combined                        RR                0.38         0.13
  Funch & Marshall, 1983 [@pmed.1000316-Funch1]                                     208                         51                    USA              20 y             Cancer                 Structural                     Combin              0.17         0.26
  Ganzini et al., 1997 [@pmed.1000316-Ganzini1]                                     100                         73                    USA             2 y 6m          All-cause                 Combined                      Combin              0.15         0.25
  Gellert et al., 1993 [@pmed.1000316-Gellert1]                                     136                         47                    USA              10 y             Cancer                 Functional                       RR               −0.24         0.40
  Giles et al., 2005 [@pmed.1000316-Giles1]                                        1,477                        80                 Australia           10 y           All-cause                Structural                        p                0.21         0.10
  Giraldi et al., 1997 [@pmed.1000316-Giraldi1]                                      74                         51                   Italy             6 y              Cancer                 Functional                     M & SD              0.14         0.43
  Glass et al., 1999 [@pmed.1000316-Glass1]                                        1,380                        72                    USA              13 y           All-cause                Structural                       RR                0.42         0.20
  Goldman et al., 1995 [@pmed.1000316-Goldman1]                                    7,478                        77                    USA              6 y            All-cause                Structural                       OR                0.30         0.06
  Goodwin et al., 1996 [@pmed.1000316-Goodwin1]                                     328                         72                    USA              10 y           All-cause                Structural                        p                0.62         0.20
  Gorkin et al.,1993 [@pmed.1000316-Gorkin1]                                       1,146                        61                    USA              10 m           All-cause                Functional                      Freq               0.23         0.28
  Grand et al., 1990 [@pmed.1000316-Grand1]                                         645                         75                  France             4 y            All-cause                 Combined                        OR                0.40         0.22
  Greenfield et al., 2002 [@pmed.1000316-Greenfield1]                              5,092                        NR                    USA              11 y           All-cause                Structural                       RR                0.38         0.14
  Greenwood et al., 1995 [@pmed.1000316-Greenwood1]                                1,274                        59                    UK               4 y            All-cause                Structural                       RR                0.43         0.17
  Grodner et al., 1996 [@pmed.1000316-Grodner1]                                     110                         63                    USA              6 y            All-cause                 Combined                      M & SD              0.50         0.35
  Gustafsson et al., 1998 [@pmed.1000316-Gustafsson1]                               421                         81                  Sweden             6 y            All-cause                Structural                       OR                0.24         0.19
  Hall et al., 1993 [@pmed.1000316-Hall1]                                          5,921                        60                  Sweden             11 y              CVD                   Structural                       OR                0.23         0.15
  Helweg-Larsen, 2003 [@pmed.1000316-HelwegLarsen1]                                6,617                        44                  Denmark            13 y           All-cause                 Combined                        RR                0.74         0.05
  Herndon et al., 1999 [@pmed.1000316-Herndon1]                                     206                         61                    USA            4 y 2 m            Cancer                 Functional                        p                0.16         0.26
  Hill et al., 2005 [@pmed.1000316-Hill1]                                          3,050                        78                    USA              8 y            All-cause                 Combined                         p                0.08         0.07
  Hirdes & Forbes, 1992 [@pmed.1000316-Hirdes1]                                     259                         45                  Canada             20 y           All-cause                 Combined                        RR                0.55         0.29
  Ho, 1991 [@pmed.1000316-Ho1]                                                      946                         77                   China             2 y            All-cause                 Combined                        RR                0.55         0.24
  House et al., 1982 [@pmed.1000316-House2]                                        2,754                        52                    USA              12 y           All-cause                Structural                     Combin              0.27         0.17
  Hummer et al., 1999 [@pmed.1000316-Hummer1]                                      21,204                       43                    USA              8 y            All-cause                Structural                      Freq               0.45         0.05
  Iribarren et al., 2005 [@pmed.1000316-Iribarren1]                                5,108                        25                    USA              16 y           All-cause                Structural                     Combin              0.60         0.21
  Irvine et al., 1999 [@pmed.1000316-Irvine1]                                       634                         64                  Canada             2 y            All-cause                Structural                       RR                0.01         0.32
  Iwasaki et al., 2002 [@pmed.1000316-Iwasaki1]                                    11,560                       55                   Japan             7 y            All-cause                 Combined                        RR                0.22         0.11
  Johnson et al., 2005 [@pmed.1000316-Johnson1]                                    3,698                        43                    USA              5 y            All-cause                 Combined                         p                0.18         0.10
  Johnson et al., 1996 [@pmed.1000316-Johnson2]                                    1,257                        64                  Sweden             14 y              CVD                   Functional                       RR                0.21         0.15
  Jorm et al., 1991 [@pmed.1000316-Jorm1]                                           228                         79                 Australia           5 y            All-cause                Functional                     M & SD              0.24         0.24
  Juon et al., 2003 [@pmed.1000316-Juon1]                                          1,091                         6                    USA              28 y           All-cause                Structural                       OR                0.60         0.35
  Jylhä and Aro, 1989 [@pmed.1000316-Jylh1]                                         936                         NR                  Finland          6 y 6 m          All-cause                 Combined                         p                0.32         0.12
  Kaplan et al., 1988 [@pmed.1000316-Kaplan1]                                      5,320                        49                  Finland            5 y            All-cause                Structural                       OR                0.75         0.18
  Kaplan et al., 1994 [@pmed.1000316-Kaplan2]                                      2,501                        53                  Finland          5 y 11m          All-cause                 Combined                        RR                0.27         0.19
  Kawachi et al., 1996 [@pmed.1000316-Kawachi1]                                    18,702                       60                    USA              4 y            All-cause                Structural                       RR                0.50         0.17
  Keller et al., 2003 [@pmed.1000316-Keller1]                                       654                         78                    USA              10 y           All-cause                Structural                        p                0.53         0.14
  Kiely et al., 2000 [@pmed.1000316-Kiely1]                                         916                         87                    USA            4 y 6 m          All-cause                Structural                        p                0.23         0.12
  Kimmel et al., 2000 [@pmed.1000316-Kimmel1]                                       174                         54                    USA              5 y            All-cause                Functional                        p                0.73         0.17
  Korten et al., 1999 [@pmed.1000316-Korten1]                                       752                         70                 Australia           4 y            All-cause                 Combined                      Combin              0.20         0.13
  Krause, 1997 [@pmed.1000316-Krause1]                                             2,209                        68                    UK               11 y           All-cause                 Combined                        OR               −0.03         0.10
  Krause, 2006 [@pmed.1000316-Krause2]                                              976                         74                    USA              3 y            All-cause                 Combined                        OR                 0           0.18
  Kroenke et al., 2006 [@pmed.1000316-Kroenke1]                                    2,835                        59                    USA              12 y           All-cause                Structural                       RR                0.45         0.22
  La Cour et al., 2005 [@pmed.1000316-LaCour1]                                      734                         70                  Denmark            20 y           All-cause                Structural                        p                0.45         0.14
  Lee & Rotheram-Borus, 2001 [@pmed.1000316-Lee1]                                   307                         38                    USA            2 y 4 m            Other                  Functional                        p                0.54         0.21
  Lehto et al., 2006 [@pmed.1000316-Lehto1]                                         101                         54                  Finland            9 y              Cancer                 Functional                        p                0.97         0.38
  Lennartsson and Silverstein, 2001 [@pmed.1000316-Lennartsson1]                    463                         82                  Sweden             4 y            All-cause                Structural                       RR                0.40         0.17
  Ljungquist et al., 1995 [@pmed.1000316-Ljungquist1]                               956                         70                  Sweden             10 y           All-cause                 Combined                        OR                1.03         0.16
  Lund et al., 2002 [@pmed.1000316-Lund1]                                          1,265                        60                  Denmark            8 y            All-cause                Structural                        p                0.37         0.16
  Lund et al., 2000 [@pmed.1000316-Lund2]                                           894                         79                  Denmark            8 y            All-cause                Structural                       OR                0.30         0.21
  Lyyra and Heikkinen, 2006 [@pmed.1000316-Lyyra1]                                  206                         80                  Finland            10 y           All-cause                 Combined                      Combin              0.25         0.30
  Maier & Smith, 1999 [@pmed.1000316-Maier1]                                        513                         85                  Germany            6 y            All-cause                Functional                     Combin              0.33         0.16
  Malmstrom et al., 2001 [@pmed.1000316-Malmstrom1]                                22,236                       47                  Sweden             8 y            All-cause                Structural                       RR                0.30         0.07
  McClellan et al., 1993 [@pmed.1000316-McClellan1]                                 210                         55                    USA              1 y            All-cause                Functional                     M & SD              0.24         0.34
  Merlo et al., 2000 [@pmed.1000316-Merlo1]                                         491                         68                  Sweden             10 y           All-cause                 Combined                       Freq               0.63         0.19
  Mertens et al., 1996 [@pmed.1000316-Mertens1]                                    1,869                        62                    USA              4 y            All-cause                Structural                     M & SD              0.56         0.08
  Morris et al., 1993 [@pmed.1000316-Morris1]                                        91                         60                    USA              10 y           All-cause                Structural                        T                0.81         0.40
  Murata et al., 2005 [@pmed.1000316-Murata1]                                      1,994                        73                   Japan           7 y 4 m          All-cause                 Combined                         p                0.12         0.11
  Murberg and Bru, 2001 [@pmed.1000316-Murberg1]                                    119                         66                  Norway             2 y               CVD                    Combined                         p                0.27         0.34
  Musick et al., 2004 [@pmed.1000316-Musick1]                                      3,617                        47                    USA            7 y 6 m          All-cause                 Combined                         R                0.17         0.06
  Nakanishi and Tatara, 2000 [@pmed.1000316-Nakanishi1]                            1,285                        74                   Japan           5 y 6 m          All-cause                Structural                        p                0.26         0.10
  Nordentoft et al., 1993 [@pmed.1000316-Nordentoft1]                               974                         41                  Denmark            10 y           All-cause                Structural                        p                0.42         0.12
  Olsen et al., 1991 [@pmed.1000316-Olsen1]                                        1,637                        79                  Denmark          15 y 6m          All-cause                 Combined                         p                0.14         0.11
  Oman and Reed, 1998 [@pmed.1000316-Oman1]                                        2,023                        75                    USA            5 y 7 m          All-cause                Structural                        P                0.20         0.11
  Orrell et al., 2000 [@pmed.1000316-Orrell1]                                        60                         80                    UK               3 y            All-cause                 Combined                         p                0.62         0.48
  Orth-Gomer and Johnson, 1987 [@pmed.1000316-OrthGomer1]                          17,433                       49                  Sweden             6 y                ?                    Structural                       RR                1.31         0.07
  Orth-Gomer and Unden, 1990 [@pmed.1000316-OrthGomer2]                             147                         57                  Sweden             10 y           All-cause                Structural                        T                0.86         0.40
  Ostbye et al., 2006 [@pmed.1000316-Ostbye1]                                      4,012                        77                    USA              10 y           All-cause                 Combined                        OR                0.54         0.09
  Oxman et al., 1995 [@pmed.1000316-Oxman1]                                         232                         76                    USA              6 m               CVD                    Combined                      Combin              0.33         0.46
  Parkerson and Gutman, 2000 [@pmed.1000316-Parkerson1]                             103                         63                    USA              1 y            All-cause                Structural                       OR                1.65         0.58
  Pennix et al., 1997 [@pmed.1000316-Pennix1]                                      2,829                        70                Netherlands          3 y            All-cause                 Combined                       Freq               0.30         0.15
  Rasulo et al., 2005 [@pmed.1000316-Rasulo1]                                      1,734                        81                  Denmark            6 y            All-cause                Structural                        p                0.11         0.09
  Reuben et al., 1992 [@pmed.1000316-Reuben1]                                       259                         73                    USA            4 y 3 m          All-cause                 Combined                         R                0.52         0.22
  Reynolds et al., 1994 [@pmed.1000316-Reynolds1]                                  1,011                        53                    USA              5 y              Cancer                  Combined                         p                0.19         0.17
  Rodriguez-Artalejo et al., 2006 [@pmed.1000316-RodriguezArtalejo1]                251                         77                   Spain             7 m               CVD                   Structural                        p                0.17         0.33
  Rosengren et al., 1998 [@pmed.1000316-Rosengren1]                                 717                         50                  Sweden             12 y           All-cause                 Combined                       Freq               0.64         0.28
  Roy et al., 1996 [@pmed.1000316-Roy1]                                             547                         80                    USA              4 y            All-cause                Structural                       RR                0.76         0.15
  Rozzini et al., 1991 [@pmed.1000316-Rozzini1]                                    1,201                        73                   Italy             3 y            All-cause                Structural                      Freq               0.94         0.20
  Ruberman et al., 1984 [@pmed.1000316-Ruberman1]                                  2,320                        50                    USA              3 y            All-cause                Structural                       Chi               0.39         0.08
  Rutledge et al., 2003 [@pmed.1000316-Rutledge1]                                  7,524                        71                    USA              6 y            All-cause                 Combined                        RR                0.53         0.05
  Rutledge et al., 2004 [@pmed.1000316-Rutledge2]                                   503                         59                    USA            2 y 4 m          All-cause                 Combined                      M & SD              0.99         0.37
  Saito-Nakaya et al., 2006 [@pmed.1000316-SaitoNakaya1]                            238                         62                   Japan           7 y 6 m          All-cause                 Combined                       Freq              −0.07         0.35
  Schoenbach et al., 1986 [@pmed.1000316-Schoenbach1]                               791                         55                    USA              2 y            All-cause                Structural                      Freq               0.80         0.19
  Seeman et al., 1993 [@pmed.1000316-Seeman1]                                      1,420                        74                    USA              5 y            All-cause                 Combined                         p                1.83         0.17
  Shahatahmasebi et al., 1992 [@pmed.1000316-Shahatahmasebi1]                       534                         72                    UK               8 y            All-cause                 Combined                        Chi               0.40         0.16
  Shmotkin et al., 2003 [@pmed.1000316-Shmotkin1]                                  1,174                        84                  Israel             8 y            All-cause                Structural                        p               −0.09         0.12
  Shye et al., 1995 [@pmed.1000316-Shye1]                                           455                         72                    USA              15 y           All-cause                Structural                      Freq               0.80         0.21
  Silverstein and Bengston, 1991 [@pmed.1000316-Silverstein1]                       435                         67                    USA              14 y           All-cause                 Combined                        OR                0.03         0.16
  Soler-Vila et al., 2003 [@pmed.1000316-SolerVila1]                                322                         54                    USA              10 y           All-cause                 Combined                      M & SD              0.29         0.20
  Stavraky et al., 1988 [@pmed.1000316-Stavraky1]                                   224                         59                  Canada             1 y              Cancer                  Combined                       Freq               0.55         0.35
  Stek et al., 2005 [@pmed.1000316-Stek1]                                           476                         85                Netherlands          5 y            All-cause                Functional                        p                0.35         0.21
  Sturdy et al., 2002 [@pmed.1000316-Sturdy1]                                      1,066                        53                    UK               5 y            All-cause                Structural                       OR                0.17         0.35
  Sugisawa et al., 1994 [@pmed.1000316-Sugisawa1]                                  1,943                        69                   Japan             3 y            All-cause                 Combined                         p                0.03         0.19
  Sun and Lui, 2006 [@pmed.1000316-Sun1]                                           7,938                        92                   China             2 y            All-cause                Structural                        R                0.67         0.04
  Temkin-Greener et al., 2004 [@pmed.1000316-TemkinGreener1]                       3,138                        79                    USA              2 y            All-cause                 Combined                         p                0.21         0.10
  Thomas et al., 1997 [@pmed.1000316-Thomas1]                                       424                         63                Canada, USA        3 y 11m             CVD                   Functional                     M & SD              0.10         0.18
  Tucker et al., 1996 [@pmed.1000316-Tucker1]                                      1,077                        12                    USA              41 y           All-cause                Structural                        p                0.27         0.12
  Vaillant et al., 1998 [@pmed.1000316-Vaillant1]                                   223                         20                    USA              25 y           All-cause                 Combined                        OR                1.15         0.37
  Vogt et al., 1992 [@pmed.1000316-Vogt1]                                          2,396                        47                    USA              15 y           All-cause                Structural                        p                0.20         0.08
  Walter-Ginzburg et al., 2002 [@pmed.1000316-WalterGinzburg1]                     1,340                        83                  Israel             8 y            All-cause                 Combined                       Freq               0.23         0.11
  Waxler-Morrison et al., 1991 [@pmed.1000316-WaxlerMorrison1]                      118                         45                  Canada             4 y              Cancer                 Structural                        p                0.27         0.36
  Weihs et al., 2005 [@pmed.1000316-Weihs1]                                          90                         52                    USA              9 y              Cancer                 Structural                     Combin              0.61         0.40
  Welin et al., 2000 [@pmed.1000316-Welin1]                                         275                         55                  Sweden             10 y           All-cause                 Combined                         p                0.44         0.22
  Welin et al., 1992 [@pmed.1000316-Welin2]                                         959                         60                  Sweden             12 y           All-cause                 Combined                      Combin              0.52         0.17
  Wilkins, 2003 [@pmed.1000316-Wilkins1]                                           2,107                        75                  Canada             6 y            All-cause                 Combined                        RR                0.05         0.12
  Woloshin et al., 1997 [@pmed.1000316-Woloshin1]                                    37                         67                  Canada             1 y            All-cause                Functional                       OR                1.87         0.61
  Yasuda et al., 1997 [@pmed.1000316-Yasuda1]                                       806                         74                    USA              5 y            All-cause                 Combined                       Freq               0.27         0.19
  Zuckerman et al., 1984 [@pmed.1000316-Zuckerman1]                                 398                         72                    USA              2 y            All-cause                 Combined                      Combin              0.09         0.18

Chi, chi-square; Combin, combined statistics; Freq, frequency counts; m, months; M & SD, means and standard deviations; NR, not reported; OR, odds ratio; RR, risk ratio; p, level of statistical significance; t, t-scores; y, years.

Omnibus Analysis {#s3a}
----------------

Across 148 studies, the random effects weighted average effect size was OR = 1.50 (95% confidence interval \[CI\] = 1.42 to 1.59), which indicated a 50% increased likelihood of survival as a function of stronger social relations. Odds ratios ranged from 0.77 to 6.50, with substantial heterogeneity across studies (*I^2^* = 81% \[95% CI = 78% to 84%\]; *Q* ~(147)~ = 790, *p*\<0.001; τ^2^ = 0.07), suggesting that systematic effect size variability was unaccounted for. Thus factors associated with the studies themselves (e.g., publication status), participant characteristics (e.g., age, health status), and the type of evaluation of social relationships (e.g., structural social networks versus perceptions of functional social support) may have moderated the overall results. We therefore conducted additional analyses to determine the extent to which these variables moderated the overall results.

To assess the possibility of publication bias [@pmed.1000316-1], we conducted several analyses. First, we calculated the fail-safe *N* [@pmed.1000316-1] to be 4,274, which is the theoretical number of unpublished studies with effect sizes averaging zero (no effect) that would be needed to render negligible the omnibus results. Second, we employed the "trim and fill" methodology described by Duval and Tweedie [@pmed.1000316-Duval1],[@pmed.1000316-Duval2] to estimate the number of studies missing due to publication bias, but this analysis failed to reveal any studies that would need to be created on the opposite side of the distribution, meaning that adjustment to the omnibus effect size was unnecessary. Third, we calculated both Egger\'s regression test and the alternative to that test recommended by Peters and colleagues [@pmed.1000316-Peters1] that is better suited to data in lnOR format. The results of both analyses failed to reach statistical significance (*p*\>0.05). Finally, we plotted a contour-enhanced funnel plot ([Figure 2](#pmed-1000316-g002){ref-type="fig"}) [@pmed.1000316-Peters2]. The data obtained from this meta-analysis were fairly symmetrical with respect to their own mean; fewer than ten studies were "missing" on the left side of the distribution that would have made the plot symmetrical. Based on these several analyses, publication bias is unlikely to threaten the results.

![Contour enhanced funnel plot.](pmed.1000316.g002){#pmed-1000316-g002}

Moderation by Social Relationship Assessment, and by Participant and Study Characteristics {#s3b}
------------------------------------------------------------------------------------------

Given that structural versus functional components of social relationships may influence health in different ways [@pmed.1000316-Lakey1],[@pmed.1000316-Cohen4], the high degree of heterogeneity observed in the omnibus results may have been due in part to differences between the components of social relationships evaluated within and across studies. Hence the remaining analyses separately evaluate effect sizes obtained from structural, functional, and combined (structural and functional) measures of social relationships. [Table 2](#pmed-1000316-t002){ref-type="table"} provides definitions of the types and subtypes of social relationships evaluated.

10.1371/journal.pmed.1000316.t002

###### Descriptive coding of the measures used to assess social relationships.

![](pmed.1000316.t002){#pmed-1000316-t002-2}

  Type of Measure                  Description                                                                                                               Example of Measure                                                                                                 
  ------------------ ---------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***Functional***                                                                                                              ***Functions provided or perceived to be available by social relationships***                                                                   
                                 Received support                                                                             Self-reported receipt of emotional, informational, tangible, or belonging support                                                                   • Inventory of Social Supportive Behaviors [@pmed.1000316-Barrera1]• UCLA Social Support Interview [@pmed.1000316-DunkelSchetter1],[@pmed.1000316-DunkelSchetter2]• Social Support Behaviors Scale [@pmed.1000316-Vaux1]
                          Perceptions of social support                                                               Perception of availability of emotional, informational, tangible, or belonging support if needed.                                                          • EPESE support questions [@pmed.1000316-Seeman2]• Malmo Social Support Scale [@pmed.1000316-Hanson1]• Social Support Questionnaire [@pmed.1000316-Sarason1]• Interpersonal Support Evaluation List [@pmed.1000316-Cohen9]
                             Perception of loneliness                                                                                    Feelings of isolation, disconnectedness, and not belonging                                                                                                                                          • Loneliness Scale [@pmed.1000316-DeJongGierveld1]• UCLA Loneliness Scale [@pmed.1000316-Russell1]
  ***Structural***                                                                                                             ***The existence and interconnections among differing social ties and roles***                                                                   
                                  Marital status                                                                                                            married versus other                                                                                                                                                                    • Binary item: Married yes, no• Married, never married, divorced, separated, widowed
                                 Social networks                                                                                             network density or size, number of social contacts                                                                                                                                                     • Convoy measure [@pmed.1000316-Kahn1]• Social Network List [@pmed.1000316-Hirsch1]
                                Social integration             Participation in a broad range of social relationships; including active engagement in a variety of social activities or relationships, and a sense of communality and identification with one\'s social roles.                • Malmo Influence, Contact, & Anchorage Measure [@pmed.1000316-Hanson2]• Social Network Index [@pmed.1000316-Cohen10],[@pmed.1000316-Cohen11]• Social Participation Scale [@pmed.1000316-House2]
                      Complex measures of social integration                                      A single measure that assesses multiple components of social integration such as marital status, network size and network participation.                                               • Social Network Index [@pmed.1000316-Berkman2]• Social Network Questionnaire [@pmed.1000316-Kahn2]• Social Connections Index [@pmed.1000316-Kaplan1]• Rand Social Health Battery [@pmed.1000316-Donald1]
                                   Living alone                                                                                                    Living alone versus living with others                                                                                                                                                                          • Binary item: yes, no• Number of people in household
                                 Social isolation                                                                    Pervasive lack of social contact or communication, participation in social activities, or confidant                                                                                                                                            • Social Isolation Scale [@pmed.1000316-Greenfield1]
  ***Combined***                                                                                                                         ***Assessment of both structural and functional measures***                                                                            
                             Multifaceted Measurement                                                                       Multiple measures obtained that assess more than one of the above conceptualizations.                                                               

### Structural aspects of social relationships {#s3b1}

Sixty-three studies had data exclusive to structural measures of social relationships (see [Figure 3](#pmed-1000316-g003){ref-type="fig"}). Across these studies, the random effects weighted average effect size was OR = 1.57 (95% CI = 1.46 to 1.70), which value fell within the CI of the omnibus results reported previously. The heterogeneity across studies was still quite large (*I^2^* = 84% \[95% CI = 80% to 87%\]; *Q* ~(62)~ = 390, *p*\<0.001; τ^2^ = 0.07), so we undertook metaregression with prespecified participant and study characteristics.

![Forest plot of structural measures.](pmed.1000316.g003){#pmed-1000316-g003}

Metaregression is an analogue to multiple regression analysis for effect sizes. Its primary purpose is to ascertain which continuous and categorical (dummy coded) variables predict variation in effect size estimates. Using random effects weighted metaregression, we examined the simultaneous association (with all variables entered into the model) between effect sizes and prespecified participant and study characteristics ([Table 3](#pmed-1000316-t003){ref-type="table"}). To examine the most precise effect size estimates available and to increase the statistical power associated with this analysis, we shifted the unit of analysis [@pmed.1000316-Borenstein1] and extracted effect sizes within studies that were specific to measures of structural aspects of social relationships. That is, if a study contained effect sizes from both structural and functional types of social relationships, we extracted the structural types for this analysis (with identical subtypes aggregated), which resulted in a total of 230 unique effect sizes across 116 studies. A total of 18% of the variance in these effect sizes was explained in the metaregression (*p*\<0.001). As can be seen in [Table 3](#pmed-1000316-t003){ref-type="table"}, effect sizes based on data controlling for other variables were lower in magnitude than those based on raw data. Moreover, effect sizes differed in magnitude across the subtype of structural social relationships measured. Complex measures of social integration were associated with larger effect size values than measures of social participation. Binary measures of whether participants lived alone (yes/no) were associated with smaller effect size values. Average random effects weighted odds ratios for the various subtypes of social relationships are reported in [Table 4](#pmed-1000316-t004){ref-type="table"}.

10.1371/journal.pmed.1000316.t003

###### Random effects metaregression for effect size estimates of structural social relationships.

![](pmed.1000316.t003){#pmed-1000316-t003-3}

  Variable                                                               B       SE      *p*      β
  ------------------------------------------------------------------- -------- ------- ------- -------
  (Constant)                                                           0.535    0.238   0.02    0.00
  Participants\' average age[a](#nt104){ref-type="table-fn"}           −0.002   0.002   0.49    −0.06
  Participant sex composition[b](#nt105){ref-type="table-fn"}                                  
  100% Female                                                          0.038    0.066   0.57    0.04
  100% Male                                                            0.049    0.068   0.48    0.05
  Participant initial health[c](#nt106){ref-type="table-fn"}           −0.103   0.085   0.23    −0.10
  Cause of mortality[d](#nt107){ref-type="table-fn"}                                           
  Cardiovascular disease                                               0.081    0.161   0.61    0.03
  Cancer                                                               −0.208   0.139   0.13    −0.12
  Length of follow-up evaluation (y)                                   −0.003   0.005   0.54    −0.05
  Measure of social relationships[e](#nt108){ref-type="table-fn"}                              
  Living alone                                                         −0.265   0.106   0.013   −0.18
  Marital status                                                       −0.097   0.074   0.19    −0.10
  Social isolation                                                     −0.144   0.178   0.42    −0.05
  Social networks                                                      −0.050   0.071   0.48    −0.06
  Complex measures of integration                                      0.255    0.095   0.007   0.20
  Geographic region of study[f](#nt109){ref-type="table-fn"}                                   
  Asia                                                                 0.057    0.154   0.71    0.05
  Europe                                                               0.221    0.134   0.10    0.25
  North America                                                        0.057    0.134   0.69    0.07
  Statistically controlled estimate[g](#nt110){ref-type="table-fn"}    −0.147   0.058   0.01    −0.17

Age at study initiation.

Contrasted with reports in which males and females were combined.

Individuals with a pre-existing medical condition contrasted with community samples.

Contrasted with all cause and all other causes.

Contrasted with measures of social participation; see [Table 2](#pmed-1000316-t002){ref-type="table"} for descriptions of each kind of measure.

Contrasted with all other world regions combined.

Contrasted with estimates based on raw data.

β, standardized beta; B, unstandardized beta; SE, standard error.

10.1371/journal.pmed.1000316.t003

###### Weighted average effect sizes across different measures of social relationships.

![](pmed.1000316.t004){#pmed-1000316-t004-4}

  Type of Measure                                                                  k    *OR*       95% CI
  -------------------------------------- ---------------------------------------- ---- ------ ----------------
  *Functional*                                   Received social support           9    1.22   \[0.91, 1.63\]
                                              Perceptions of social support        73   1.35   \[1.22, 1.49\]
                                                  Loneliness (inversed)            8    1.45   \[1.08, 1.94\]
  *Structural*                                   Living alone (inversed)           17   1.19   \[0.99, 1.44\]
                                          Marital status (married versus other)    62   1.33   \[1.20, 1.48\]
                                               Social isolation (inversed)         8    1.40   \[1.06, 1.86\]
                                                     Social networks               71   1.45   \[1.32, 1.59\]
                                                    Social integration             45   1.52   \[1.36, 1.69\]
                                          Complex measures of social integration   30   1.91   \[1.63, 2.23\]
  *Combined structural and functional*           Multifaceted measurement          67   1.47   \[1.34, 1.60\]

These analyses shifted the units of analysis, with distinct effect size estimates within studies used within different categories of measurement, such that many studies contributed more than one effect size but not more than one per category of measurement.

*OR*, odds ratio, transformed from random effects weighted lnOR.

### Functional aspects of social relationships {#s3b2}

Twenty-four studies had data exclusive to functional measures of social relationships (see [Figure 4](#pmed-1000316-g004){ref-type="fig"}). Across these studies, the random effects weighted average effect size was OR = 1.46 (95% CI = 1.28 to 1.66), which value fell within the CI of the omnibus results reported previously. There was moderate heterogeneity across studies (*I^2^* = 47% \[95% CI = 16% to 68%\]; *Q* ~(23)~ = 44, *p*\<0.01; τ^2^ = 0.04), so we conducted a random effects metaregression using the same variables and analytic procedures described previously. We extracted 87 unique effect sizes that were specific to measures of functional social relationships within 72 studies. A total of 16.5% of the variance in these effect sizes was explained in the metaregression, but the model did not reach statistical significance (*p* = 0.46). The results were not moderated by any of the specified participant characteristics (age, sex, initial health status, cause of mortality) or study characteristics (length of follow-up, geographic region, statistical controls).

![Forest plot of functional measures.](pmed.1000316.g004){#pmed-1000316-g004}

### Combined assessments of social relationships {#s3b3}

Sixty-one studies had combined data of both structural and functional measures of social relationships (see [Figure 5](#pmed-1000316-g005){ref-type="fig"}). Across these studies, the random effects weighted average effect size was OR = 1.44 (95% CI = 1.32 to 1.58). A large degree of heterogeneity characterized studies (*I^2^* = 82% \[95% CI = 78% to 86%\]; *Q* ~(60)~ = 337, *p*\<0.001; τ^2^ = 0.09), and we conducted a random effects metaregression using the same variables and analytic procedures described previously. We extracted 64 unique effect sizes that evaluated combined structural and functional measures of social relationships within 61 studies. The metaregression explained only 6.8% of the variance in these effect sizes, and the model failed to reach statistical significance (*p* = 0.95). None of the variables in the metaregression moderated the results.

![Forest plot of combined measures.](pmed.1000316.g005){#pmed-1000316-g005}

Discussion {#s4}
==========

Cumulative empirical evidence across 148 independent studies indicates that individuals\' experiences within social relationships significantly predict mortality. The overall effect size corresponds with a 50% increase in odds of survival as a function of social relationships. Multidimensional assessments of social integration yielded an even stronger association: a 91% increase in odds of survival. Thus, the magnitude of these findings may be considered quite large, rivaling that of well-established risk factors ([Figure 6](#pmed-1000316-g006){ref-type="fig"}). Results also remained consistent across a number of factors, including age, sex, initial health status, follow-up period, and cause of death, suggesting that the association between social relationships and mortality may be generalized.

![Comparison of odds (lnOR) of decreased mortality across several conditions associated with mortality.\
Note: Effect size of zero indicates no effect. The effect sizes were estimated from meta analyses: ; A = Shavelle, Paculdo, Strauss, and Kush, 2008 [@pmed.1000316-Shavelle1]; B = Critchley and Capewell, 2003 [@pmed.1000316-Critchley1]; C = Holman, English, Milne, and Winter, 1996 [@pmed.1000316-Holman1]; D = Fine, Smith, Carson, Meffe, Sankey, Weissfeld, Detsky, and Kapoor, 1994 [@pmed.1000316-Fine1]; E = Taylor, Brown, Ebrahim, Jollife, Noorani, Rees et al., 2004 [@pmed.1000316-Taylor1]; F, G = Katzmarzyk, Janssen, and Ardern, 2003 [@pmed.1000316-Katzmarzyk1]; H = Insua, Sacks, Lau, Lau, Reitman, Pagano, and Chalmers, 1994 [@pmed.1000316-Insua1]; I = Schwartz, 1994 [@pmed.1000316-Schwartz1].](pmed.1000316.g006){#pmed-1000316-g006}

The magnitude of risk reduction varied depending on the type of measurement of social relationships (see [Table 4](#pmed-1000316-t004){ref-type="table"}). Social relationships were most highly predictive of reduced risk of mortality in studies that included multidimensional assessments of social integration. Because these studies included more than one type of social relationship measurement (e.g., network based inventories, marital status, etc.), such a measurement approach may better represent the multiple pathways (described earlier) by which social relationships influence health and mortality [@pmed.1000316-Uchino1]. Conversely, binary evaluations of living alone (yes/no) were the least predictive of mortality status. The reliability and validity of measurement likely explains this finding, and researchers are encouraged to use psychometrically sound measures of social relationships (e.g., [Table 2](#pmed-1000316-t002){ref-type="table"}). For instance, while researchers may be tempted to use a simple single-item such as "living alone" as a proxy for social isolation, it is possible for one to live alone but have a large supportive social network and thus not adequately capture social isolation. We also found that social isolation had a similar influence on likelihood of mortality compared with other measures of social relationships. This evidence qualifies the notion of a threshold effect (lack of social relationships is the only detrimental condition); rather, the association appears robust across a variety of types of measures of social relationships.

This meta-analysis also provides evidence to support the directional influence of social relationships on mortality. Most of the studies (60%) involved community cohorts, most of whom would not be experiencing life-threatening conditions at the point of initial evaluation. Moreover, initial health status did not moderate the effect of social relationships on mortality. Although illness may result in poorer or more restricted social relationships (social isolation resulting from physical confinement), such that individuals closer to death may have decreased social support compared to healthy individuals, the findings from these studies indicate that general community samples with strong social relationships are likely to remain alive longer than similar individuals with poor social relations. However, causality is not easily established. One cannot randomly assign human participants to be socially isolated, married, or in a poor-quality relationship. A similar dilemma characterizes virtually all lifestyle risk factors for mortality: for instance, one cannot randomly assign individuals to be smokers or nonsmokers. Despite such challenges, "smoking represents the most extensively documented cause of disease ever investigated in the history of biomedical research" [@pmed.1000316-Samet1]. The link between social relationships and mortality is currently much less understood than other risk factors; nonetheless there is substantial experimental, cross-sectional, and prospective evidence linking social relationships with multiple pathways associated with mortality (see [@pmed.1000316-Uchino1] for review). Existing models for reducing risk of mortality may be substantially strengthened by including social relationship factors.

Notably, the overall effect for social relationships on mortality reported here may be a conservative estimate. Many studies included in the meta-analysis utilized single item measures of social relations, yet the magnitude of the association was greatest among those studies utilizing complex assessments. Moreover, because many studies statistically adjusted for standard risk factors, the effect may be underestimated, since some of the impact of social relationships on mortality may be mediated through such factors (e.g., behavior, diet, exercise). Additionally, most measures of social relations did not take into account the *quality* of the social relationships, thereby assuming that all relationships are positive. However, research suggests this is not the case, with negative social relationships linked to greater risk of mortality [@pmed.1000316-Friedman1],[@pmed.1000316-Tucker2]. For instance, marital status is widely used as a measure of social integration; however, a growing literature documents its divergent effects based on level of marital quality [@pmed.1000316-Coyne2],[@pmed.1000316-Eaker1]. Thus the effect of positive social relationships on risk of mortality may actually be much larger than reported in this meta-analysis, given the failure to account for negative or detrimental social relationships within the measures utilized across studies.

Other possible limitations of this review should be acknowledged. Statistical controls (e.g., age, sex, physical condition, etc.) employed by many of the studies rule out a number of potentially confounding variables that might account for the association between social relationships and mortality. However, studies used an inconsistent variety of controlling variables, and some reports involved raw data ([Table 1](#pmed-1000316-t001){ref-type="table"}). Although effect size magnitude was diminished by the inclusion of statistical controls only within the data obtained by measures of structural social relationships (but not functional or combined measures), future research can better specify which variables are most likely to impact the overall association. It must also be acknowledged that existing data primarily represent research conducted in North America and Western Europe. Although we found no differences across world region, future reviews inclusive of research written in all languages (not only English) with participants better representing other world regions may yield better estimates across populations.

Approximately two decades after the review by House and colleagues [@pmed.1000316-House1], a generation of empirical research validates their initial premise: Social relationships exert an independent influence on risk for mortality comparable with well established risk factors for mortality ([Figure 6](#pmed-1000316-g006){ref-type="fig"}). Although limited by the state of current investigations and possible omission of pertinent reports, this meta-analysis provides empirical evidence (nearly 30 times the number of studies previously reported) to support the criteria for considering insufficient social relationships a risk factor of mortality (i.e., strength and consistency of association across a wide range of studies, temporal ordering, and gradient of response) [@pmed.1000316-Rothman1]. The magnitude of the association between social relationships and mortality has now been established, and this meta-analysis provides much-needed clarification regarding the social relationship factor(s) most predictive of mortality. Future research can shift to more nuanced questions aimed at (a) understanding the causal pathways by which social participation promotes health, (b) refining conceptual models, and (c) developing effective intervention and prevention models that explicitly account for social relations.

Some steps have already been taken identifying the psychological, behavioral, and physiological pathways linking social relationships to health [@pmed.1000316-Cohen1],[@pmed.1000316-Uchino1],[@pmed.1000316-Uchino2]. Social relationships are linked to better health practices and to psychological processes, such as stress and depression, that influence health outcomes in their own right [@pmed.1000316-Rozanski1]; however, the influence of social relationships on health cannot be completely explained by these processes, as social relationships exert an independent effect. Reviews of such findings suggest that there are multiple biologic pathways involved (physiologic regulatory mechanisms, themselves intertwined) that in turn influence a number of disease endpoints [@pmed.1000316-Uchino1],[@pmed.1000316-Cohen7]--[@pmed.1000316-Uchino4]. For instance, a number of studies indicate that social support is linked to better immune functioning [@pmed.1000316-Lutgendorf1]--[@pmed.1000316-Cohen8] and to immune-mediated inflammatory processes [@pmed.1000316-KiecoltGlaser1]. Thus interdisciplinary work and perspective will be important in future studies given the complexity of the phenomenon.

Perhaps the most important challenge posed by these findings is how to effectively utilize social relationships to reduce mortality risk. Preliminary investigations have demonstrated some risk reduction through formalized social interventions [@pmed.1000316-Spiegel1]. While the evidence is mixed [@pmed.1000316-Berkman1],[@pmed.1000316-Cohen2], it should be noted that most social support interventions evaluated in the literature thus far are based on support provided from strangers; in contrast, evidence provided in this meta-analysis is based almost entirely on naturally occurring social relationships. Moreover, our analyses suggest that received support is less predictive of mortality than social integration ([Table 4](#pmed-1000316-t004){ref-type="table"}). Therefore, facilitating patient use of naturally occurring social relations and community-based interventions may be more successful than providing social support through hired personnel, except in cases in which patient social relations appear to be detrimental or absent. Multifaceted community-based interventions may have a number of advantages because such interventions are socially grounded and include a broad cross-section of the public. Public policy initiatives need not be limited to those deemed "high risk" or those who have already developed a health condition but could potentially include low- and moderate-risk individuals earlier in the risk trajectory [@pmed.1000316-Altman1]. Overall, given the significant increase in rate of survival (not to mention quality of life factors), the results of this meta-analysis are sufficiently compelling to promote further research aimed at designing and evaluating interventions that explicitly account for social relationship factors across levels of health care (prevention, evaluation, treatment compliance, rehabilitation, etc.).

Conclusion {#s4a}
----------

Data across 308,849 individuals, followed for an average of 7.5 years, indicate that individuals with adequate social relationships have a 50% greater likelihood of survival compared to those with poor or insufficient social relationships. The magnitude of this effect is comparable with quitting smoking and it exceeds many well-known risk factors for mortality (e.g., obesity, physical inactivity). These findings also reveal significant variability in the predictive utility of social relationship variables, with multidimensional assessments of social integration being optimal when assessing an individual\'s risk for mortality and evidence that social isolation has a similar influence on mortality to other measures of social relationships. The overall effect remained consistent across a number of factors, including age, sex, initial health status, follow-up period, and cause of death, suggesting that the association between social relationships and mortality may be general, and efforts to reduce risk should not be isolated to subgroups such as the elderly.

To draw a parallel, many decades ago high mortality rates were observed among infants in custodial care (i.e., orphanages), even when controlling for pre-existing health conditions and medical treatment [@pmed.1000316-Spitz1]--[@pmed.1000316-UNICEF1]. Lack of human contact predicted mortality. The medical profession was stunned to learn that infants would die without social interaction. This single finding, so simplistic in hindsight, was responsible for changes in practice and policy that markedly decreased mortality rates in custodial care settings. Contemporary medicine could similarly benefit from acknowledging the data: Social relationships influence the health outcomes of adults.

Physicians, health professionals, educators, and the public media take risk factors such as smoking, diet, and exercise seriously; the data presented here make a compelling case for social relationship factors to be added to that list. With such recognition, medical evaluations and screenings could routinely include variables of social well-being; medical care could recommend if not outright promote enhanced social connections; hospitals and clinics could involve patient support networks in implementing and monitoring treatment regimens and compliance, etc. Health care policies and public health initiatives could likewise benefit from explicitly accounting for social factors in efforts aimed at reducing mortality risk. Individuals do not exist in isolation; social factors influence individuals\' health though cognitive, affective, and behavioral pathways. Efforts to reduce mortality via social relationship factors will require innovation, yet innovation already characterizes many medical interventions that extend life at the expense of quality of life. Social relationship--based interventions represent a major opportunity to enhance not only the quality of life but also survival.
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